Trial intelligence / Profile preview

Multiple-dose pharmacokinetic study of arimoclomol in healthy young men

NL-OMON45787Completed

Sponsor
Orphazyme A/S
Start
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

Trial of arimoclomol, sponsored by Orphazyme A/S. Started Sep 2018; status: completed.

02

Drugs

arimoclomol

Beyond the preview

Go deeper on NL-OMON45787.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON45787.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call